325 related articles for article (PubMed ID: 32387262)
1. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment.
O'Driscoll L
Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262
[No Abstract] [Full Text] [Related]
2. The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?
Mozzini C; Girelli D
Thromb Res; 2020 Jul; 191():26-27. PubMed ID: 32360977
[No Abstract] [Full Text] [Related]
3. Stem Cell-Based Therapy for Coronavirus Disease 2019.
Zhao RC
Stem Cells Dev; 2020 Jun; 29(11):679-681. PubMed ID: 32292113
[TBL] [Abstract][Full Text] [Related]
4. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cell Therapy Can Transcend Perianal Crohn's Disease: How Colorectal Surgeons Can Help in the Coronavirus Disease 2019 Crisis.
Lightner AL; García-Olmo D
Dis Colon Rectum; 2020 Jul; 63(7):874-878. PubMed ID: 32251143
[No Abstract] [Full Text] [Related]
6. Cell-Free Therapies: Novel Approaches for COVID-19.
Maron-Gutierrez T; Rocco PRM
Front Immunol; 2020; 11():583017. PubMed ID: 33072130
[No Abstract] [Full Text] [Related]
7. Expanded Mesenchymal Stem Cells: a novel therapeutic approach of SARS-CoV-2 pneumonia (COVID-19). Concepts regarding a first case in Spain.
Soler Rich R; Rius Tarruella J; Melgosa Camarero MT
Med Clin (Barc); 2020 Oct; 155(7):318-319. PubMed ID: 32753110
[No Abstract] [Full Text] [Related]
8. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell research progress for the treatment of COVID-19.
Yao D; Ye H; Huo Z; Wu L; Wei S
J Int Med Res; 2020 Sep; 48(9):300060520955063. PubMed ID: 32972277
[TBL] [Abstract][Full Text] [Related]
11. [Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review].
Shi X; Yu L; Ding C
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1979-1991. PubMed ID: 33169564
[TBL] [Abstract][Full Text] [Related]
12. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19.
Khoury M; Cuenca J; Cruz FF; Figueroa FE; Rocco PRM; Weiss DJ
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32265310
[TBL] [Abstract][Full Text] [Related]
13. Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome.
Steinhardt MJ; Wiebecke S; Weismann D; Frantz S; Tony HP; Klinker H; Schmalzing M
Scand J Rheumatol; 2020 Sep; 49(5):414-416. PubMed ID: 32914670
[No Abstract] [Full Text] [Related]
14. Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019.
Ji F; Li L; Li Z; Jin Y; Liu W
Stem Cells Transl Med; 2020 Jul; 9(7):813-814. PubMed ID: 32320535
[No Abstract] [Full Text] [Related]
15. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
Wang J; Zou W; Liu J
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
Zayed M; Iohara K
Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy.
Sleem A; Saleh F
Curr Res Transl Med; 2020 Aug; 68(3):105-110. PubMed ID: 32616467
[TBL] [Abstract][Full Text] [Related]
18. On the plausibility of late neuropsychiatric manifestations associated with the COVID-19 pandemic.
André A; Félix C; Corvacho M; Nzwalo H
J Neurol Sci; 2020 Oct; 417():117060. PubMed ID: 32739501
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
Golchin A; Seyedjafari E; Ardeshirylajimi A
Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
